Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry.
Sabaté M, Brugaletta S, Abizaid A, Banning A, Bartorelli A, Džavík V, Ellis S, Holmes D, Gao R, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Stoll HP, Worthley S, Urban P; e-SELECT Investigators. Sabaté M, et al. Among authors: brugaletta s. Int J Cardiol. 2013 Oct 3;168(3):2522-7. doi: 10.1016/j.ijcard.2013.03.064. Epub 2013 Apr 18. Int J Cardiol. 2013. PMID: 23602865 Free article.
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Valgimigli M, Campo G, de Cesare N, Meliga E, Vranckx P, Furgieri A, Angiolillo DJ, Sabatè M, Hamon M, Repetto A, Colangelo S, Brugaletta S, Parrinello G, Percoco G, Ferrari R; Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators. Valgimigli M, et al. Among authors: brugaletta s. Circulation. 2009 Jun 30;119(25):3215-22. doi: 10.1161/CIRCULATIONAHA.108.833236. Epub 2009 Jun 15. Circulation. 2009. PMID: 19528337 Clinical Trial.
Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation.
Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-Del Blanco B, Martí G, Cascant P, Martín-Yuste V, Brugaletta S, Sabaté M, Alfonso F, Capote ML, De La Torre JM, Ruíz-Lera M, Sanmiguel D, Cárdenas M, Pujol B, Baz JA, Iñiguez A, Trillo R, González-Béjar O, Casanova J, Sánchez-Gila J, García-Dorado D. Ferreira-González I, et al. Among authors: brugaletta s. Circulation. 2010 Sep 7;122(10):1017-25. doi: 10.1161/CIRCULATIONAHA.110.938290. Epub 2010 Aug 23. Circulation. 2010. PMID: 20733100 Clinical Trial.
Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry.
Martin-Yuste V, Brugaletta S, Ferreira-González I, Cola C, Alvarez-Contreras L, de Antonio M, Martí V, García-Picart J, Sabaté M. Martin-Yuste V, et al. Among authors: brugaletta s. EuroIntervention. 2011 Feb;6(7):831-7. doi: 10.4244/EIJV6I7A143. EuroIntervention. 2011. PMID: 21252017
[Usefulness of the Tornus® catheter in nondilatable coronary chronic total occlusion].
Martín-Yuste V, Alvarez-Contreras L, Cola C, Brugaletta S, García Picart J, Martí V, Masotti M, Sabaté M. Martín-Yuste V, et al. Among authors: brugaletta s. Rev Esp Cardiol. 2011 Oct;64(10):935-8. doi: 10.1016/j.recesp.2011.01.011. Epub 2011 Jun 12. Rev Esp Cardiol. 2011. PMID: 21664754 Free article. Spanish.
398 results